Minoza, Shemie P.
HRN: 24-51-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2024
CEFUROXIME 1.5GM (VIAL)
01/25/2024
01/27/2024
IV
1.5grams
Q8hrs X 3 Doses
S/P Primary LTCS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes